Rising Chronic Disease Prevalence Fuels Promising Growth Prospects for the Chemoinformatics Market || ChemAxon Ltd., Jubilant Biosys Inc., BIOVIA, OpenEye Scientific Software Inc

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Chemoinformatics Global Market Report 2023 identifies the surging prevalence of chronic diseases is the major driver for the Chemoinformatics market's growth in the forecast period. Chronic diseases refer to illnesses that last a year or longer and require ongoing medical attention. The rising number of chronic diseases such as neglected tropical diseases demands the need for new drug discoveries and the search for novel chemicals for their treatment, for which chemoinformatic is used. For instance, according to the World Health Organization, a Switzerland-based organization for international public health, between 2020 and 2030, 500 million people are expected to develop chronic diseases such as obesity, diabetes, heart diseases, or other noncommunicable diseases (NCDs) due to physical inactivity, if governments globally do no take immediate action to promote exercises.

The global chemoinformatics market size grew from $4.15 billion in 2022 to $4.31 billion in 2023 at a compound annual growth rate (CAGR) of 3.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The market size of the global chemoinformatics is expected to grow to $4.79 billion in 2027 at a CAGR of 2.7%.

Download Free Sample Of Chemoinformatics Market Report - https://www.thebusinessresearchcompany.com/sample_request?id=7806&type=smp

Major competitors in the chemoinformatics market are ChemAxon Ltd., Jubilant Biosys Inc., BIOVIA, OpenEye Scientific Software Inc., Schrödinger Inc., Advanced Chemistry Development Inc., Scilligence Corporation, Dassault Systemes SE, Chemical Computing Group Inc., Collaborative Drug Discovery Inc.

A key trend in the chemoinformatics market includes offering technological advances. Major companies operating in the market are developing software and platforms with advanced technologies to sustain their position in the market. For instance, in January 2021, Optibrium, a UK-based developer of software for drug discovery launched the latest version of StarDropTM, a comprehensive software platform for small molecule creation, optimization, and data analysis. The latest update, StarDrop 7.0, gives drug discovery scientists access to unique artificial intelligence (AI) technology capabilities while also extending the software's compound design techniques, delivering improved workflows, and integrating with Optibrium's CerellaTM platform.

Read More On The Global Chemoinformatics Market Report Here: https://www.thebusinessresearchcompany.com/report/chemoinformatics-global-market-report

The chemoinformatics market is segmented -

1) By Type: Chemistry, Computer Science, Information Science

2) By Application: Chemical Analysis, Drug Discovery and Validation, Virtual Screening, Other Applications

3) By End User: Chemical and Pharmaceutical Industries, Research and Academic Institution, Other End Users

4) By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the chemoinformatics market.

The Business Research Company's "Global Chemoinformatics Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Chemoinformatics Market Report Here: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7806

The Table Of Content For The Chemoinformatics Market Include:
1. Executive Summary
2. Chemoinformatics Market Characteristic
3. Chemoinformatics Market Trends And Strategies
4. Chemoinformatics Market - Macro Economic Scenario
5. Chemoinformatics Market Size And Growth
……………
27. Chemoinformatics Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Chemoinformatics Market
29. Chemoinformatics Market Future Outlook And Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.